These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3571773)

  • 1. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
    Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
    J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
    Nathan RA; Bodman SF; Storms WW; Mingo TS
    Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
    Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
    Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
    Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
    Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
    Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
    J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma.
    Bierman CW; Kemp JP; Nathan RA
    Ann Allergy Asthma Immunol; 1996 Jan; 76(1):27-35. PubMed ID: 8564625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
    Orgel HA; Kemp JP; Tinkelman DG; Webb DR
    J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
    Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
    Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitolterol mesylate in exercise-induced asthma.
    Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
    J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
    Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
    J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
    Minatoya H
    J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring.
    Kemp JP; Chervinsky P; Orgel HA; Meltzer EO; Noyes JH; Mingo TS
    J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):32-43. PubMed ID: 6693665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects.
    Kass I; Mingo TS
    Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.
    Friedel HA; Brogden RN
    Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma.
    Walker SB; Kradjan WA; Bierman CW
    Pharmacotherapy; 1985; 5(3):127-37. PubMed ID: 3895171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bitolterol compared to isoproterenol in advanced chronic obstructive pulmonary disease.
    Petty TL; Scoggin CH; Rollins DR; Repsher LH
    Chest; 1984 Sep; 86(3):404-8. PubMed ID: 6380974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS
    Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator effects of nebulized fenoterol: a comparison with isoproterenol.
    Watanabe S; Turner WG; Renzetti AD; Harless KW; Bigler AH; Cutillo A
    Chest; 1981 Sep; 80(3):292-9. PubMed ID: 7023862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of nebulized ipratropium in severely asthmatic children.
    Qureshi F; Zaritsky A; Lakkis H
    Ann Emerg Med; 1997 Feb; 29(2):205-11. PubMed ID: 9018183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.